Home Blog Contact
Log in Register
MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

73 articles published

All Market Updates (8967) Corporate announcement (8258) Financial Results (3178) Earnings conference call (344) Chartink scans (124) BSE filings (119) NSE filings (72) TECHNOCRAFT INDUSTRIES (INDIA) (52) Live gainers (47) Network People Services Technologies (41)

Results for “SCI” · in Market Updates — Clear filters

IGCL
IGCL
1 min read
Market Updates Corporate announcement

Indogulf Cropsciences (IGCL): Company Update

Company Update Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26 Earnings Call Presentation of the Company pertaining to Q4 of FY 2025-26

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Company Update

Company Update Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA. Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences (ZYDUSLIFE): Press Release

Press Release Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA". Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority

Read article
SUVEN
SUVEN
1 min read
Market Updates Chartink scans

Suven Life Sciences (SUVEN): 🚀 Volume Explosion: SUVEN Breaks 60-Day Average!

💹 Change: ▼ -2.34% 💰 Price: ₹268.90 📊 Volume: 2.41M 🔍 What's happening? Unusual trading activity detected! This could signal a potential breakout or significant news impact. 💡 Pro Tip: Always conduct thorough research before making investment decisions.

Read article
SUVEN
SUVEN
1 min read
Market Updates Chartink scans

SUVEN Stock at ₹273.40 with Unusual Volume Activity — ZTOX Daily Scan

Suven Life Sciences (SUVEN) stock fell 0.71% to ₹273.40 with 2.22 million shares traded, signaling unusual trading activity on Tuesday.

Read article
SUVEN
SUVEN
1 min read
Market Updates NSE filings

Suven Life Sciences DSMB Review: Phase 3 Masupirdine Study Advances

Suven Life Sciences (NSE: SUVEN) announced positive findings from a DSMB safety review and interim analysis of its ongoing global Phase 3 study of Masupirdine for Alzheimer's Disease Agitation.

Read article
BAYERCROP
BAYERCROP
1 min read
Market Updates Corporate announcement

Bayer CropScience Releases FY2026 Audited Financial Results

Bayer CropScience has published its audited financial results for the financial year ended March 31, 2026, via official BSE disclosure as per SEBI regulations.

Read article
ZYDUSLIFE
ZYDUSLIFE
1 min read
Market Updates Corporate announcement

Zydus Lifesciences Subsidiary Gets CGST Demand Order from Ahmedabad Authority

Zydus VTEC Limited, the wholly owned subsidiary of Zydus Lifesciences, has received a Demand Order-In-Original from the Deputy Commissioner of CGST & Central Excise based in Ahmedabad North Commissionerate.

Read article

Live Updates

Quick Notification

AI Insights

Smart analysis of market trends

Smart Alerts

Notifications on crucial events

WhatsApp & Telegram

Alerts in the chat you already use

FREE PLAN · PAID UPGRADES FROM ₹89/MO

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Free 5 companies
Basic 20 companies
Pro Up to 500 companies
Get started free
A

"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."

— Aditya M., Active Trader